Skip to main content
Sirnaomics Ltd. logo

Sirnaomics Ltd. — Investor Relations & Filings

Ticker · 2257 ISIN · KYG2050P1028 LEI · 2549004JEEDTBC6EHW37 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 403 across all filing types
Latest filing 2022-09-29 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 2257

About Sirnaomics Ltd.

http://www.sirnaomics.com

Sirnaomics Ltd. is a clinical-stage RNA therapeutics biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs. The company's pipeline addresses a broad spectrum of therapeutic areas, including oncology, fibrosis-related diseases, skin conditions, antiviral and cardiometabolic diseases, and medical aesthetics. Sirnaomics utilizes proprietary delivery platforms, which form the foundation of its RNA-based therapeutics. These platforms include the Polypeptide Nanoparticle (PNP) system for administering mRNA vaccines and therapeutics, and the GalNAc delivery platform for systemic administration of liver-targeting RNA interference (RNAi) therapeutics. The company is recognized as the first to achieve positive Phase IIb clinical outcomes in oncology using clinical-stage RNA therapeutics.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Sirnaomics Ltd. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these repurchases comply with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing about share capital changes and repurchases. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2022-09-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Sirnaomics Ltd. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these repurchases comply with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases, not a financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing about share transactions. Therefore, it fits best under the category 'Transaction in Own Shares' (POS). The document length and detail support this classification with high confidence.
2022-09-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Sirnaomics Ltd. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these repurchases comply with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It is not an announcement of a report publication but a substantive regulatory filing about share capital changes and repurchases. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2022-09-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Sirnaomics Ltd. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these transactions comply with listing rules of the Stock Exchange of Hong Kong (SEHK). The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It is a formal notification of share capital changes and repurchase activities, fitting the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transactional data, confirming it is not a brief announcement or a certification letter. Therefore, the appropriate classification is POS.
2022-09-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Sirnaomics Ltd. It includes detailed tables of repurchases of shares, dates, prices, and confirmations that the repurchases were authorized and complied with listing rules. The document references specific listing rules of the Stock Exchange of Hong Kong (SEHK) and provides detailed transactional data on share repurchases. This type of document is a report of the company buying back its own shares, which fits the definition of 'Transaction in Own Shares' (POS). The document length is substantial (11,863 characters) and contains detailed transactional data, not just an announcement or a brief summary, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS with high confidence.
2022-09-23 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Sirnaomics Ltd. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these repurchases comply with listing rules of the Stock Exchange of Hong Kong. The content focuses on reporting share repurchase transactions and changes in share capital, which aligns with announcements of share buybacks or capital changes. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a proxy statement, AGM material, or legal proceeding. It is a regulatory disclosure specifically about share repurchases and capital changes. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2022-09-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.